1) lymphatic chemical thrapy
腹腔淋巴化疗
3) abdominal lymph node
腹腔淋巴结
1.
The clinical study on metastasis of abdominal lymph node for carcinoma of the thoracic esophagus;
胸段食管癌腹腔淋巴结转移的临床分析
4) Intraperitoneal chemotherapy
腹腔化疗
1.
Arterial infusion chemotherapy combining with intraperitoneal chemotherapy for patients with advanced cancer of urinary bladder.;
动脉插管化疗联合腹腔化疗治疗晚期膀胱癌
2.
Clinical research of intraperitoneal chemotherapy plus Shenmai Injection in treating advanced colorectal cancer;
参麦针剂协同腹腔化疗治疗进展期大肠癌的临床观察
3.
Curative effect of intraperitoneal chemotherapy with 5-Fluorouracil and 10-Hydroxycamptothecin combining with Ping Xiao pian in advanced hepatic carcinoma.;
5-Fu加HCPT腹腔化疗联合平消片治疗晚期肝癌
5) Chemotherapy
[英][,ki:məʊ'θerəpi] [美]['kimo'θɛrəpɪ]
腹腔化疗
1.
Arterial catheterization plus general chemotherapy for 56 cases of middle or advanced hepatic carcinoma;
动脉介入联合腹腔化疗治疗中晚期肝癌56例
2.
Our aim was to investigate the protective effects of glutamine for the morphological and functional damage of gastrointestinal mucosa induced by introperitoneally fluorouracil(5-FU) in rats in order to find the ways to prevent the intestinal mucosa from damage in the period of chemotherapy.
方法:Wistar大鼠随机分为空白对照组(A组)、模型组(B组,氟尿嘧啶(5-FU)腹腔化疗)、对照组(C组,5-FU+甘氨酸)和治疗组(D组,5-FU+谷氨酰胺),每组各10只大鼠。
6) lymphatic chemotherapy
淋巴化疗
1.
Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer;
术前淋巴化疗对乳腺癌腋窝转移癌细胞Bcl-2和Bax蛋白表达的影响
2.
From the character of rectal cancer metastasis and the results of other solid tumor lymphatic chemotherapy, we think rectal cancer lymphatic chemotherapy maybe also have great significance.
根据结直肠癌的转移特性及其他实体瘤淋巴化疗研究成果认为直肠癌的淋巴化疗可能也具有重要意义。
补充资料：腹腔化疗
腹腔化疗
腹腔化疗是指应用抗癌药(稀释后)经腹腔灌注对盆腔和(或)腹腔内恶性肿瘤进行化疗的一种治疗方法。在女性癌中，最常用于卵巢癌。腹腔化疗的主要优点是肿瘤局部抗癌药的浓度高(较血浆内药浓度高10～1000倍)。因此，可增加肿瘤局部抗癌效果而降低全身毒副反应。其主要不足是属于腹腔内局部治疗，对腹腔外转移瘤的疗效差；即使腹腔内，药物对肿瘤的穿透力也有限，故单用腹腔化疗有一定局限性，多与静脉化疗联合应用。其适应证有：①盆腔、腹腔内小体积种植瘤，如卵巢癌行肿瘤减灭术后残留体积较小的肿瘤。体积愈小，疗效愈好，一般最大体积不超过2cm直径大小的疗效较好；②晚期癌伴有腹水者，用以控制腹水；③手术及系统化疗完成后，临床无癌，二次剖腹探查术阴性(病理检查未发现癌)者，用以巩固化疗。应用方法有两种：一种是腹腔置管法：即于肿瘤减灭术后，关腹前腹腔内放置导管一根，导管外端与腹壁皮下埋植注射泵(于手术完毕放置)连接，术后于埋植注射泵部位的皮肤消毒后即可经此注射泵进行腹腔化疗。术后重复腹腔化疗，操作简便。但可发生导管与周围组织粘连、导管堵塞、因粘连致抗癌药分布不匀、甚至肠管损伤以及继发感染等合并症。另一种是单次腹腔穿刺法：每次腹腔化疗均须行腹腔穿刺术，但较腹腔置管法的合并症明显减少。但如果盆、腹腔内已有粘连，穿刺时也易发生肠管或其他脏器损伤。因此，必须正确操作、严格消毒注意避免上述合并症的发生。并应注意对抗癌药的毒副性作用的防治。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条